hl-085
Small moleculeexperimental
Clinical trial activity
10 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2017 (NCT03973151)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05900219 | Phase 2 | Sep 24, 2023 | Chinese Academy of Medical Sciences, Kechow Pharma |
| NCT05233332 | Phase 2 | Feb 28, 2022 | Kechow Pharma |
| NCT05331105 | Phase 2 | Oct 18, 2021 | Kechow Pharma |
| NCT05263453 | Phase 2 | Sep 6, 2021 | Kechow Pharma |
| NCT04683354 | Phase 1 | Dec 31, 2020 | Kechow Pharma |
| NCT05217303 | Phase 2 | Nov 2, 2020 | Kechow Pharma |
| NCT03990077 | Phase 1 | Jul 31, 2019 | Kechow Pharma |
| NCT03976050 | Phase 1 | Jun 17, 2019 | Kechow Pharma |
| NCT03781219 | Phase 1 | Jul 1, 2018 | Kechow Pharma |
| NCT03973151 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2017 | Kechow Pharma |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kechow Pharma | For profit | 10 | 10 | 2 | 2017 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1